These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22932213)

  • 21. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus.
    Mun SH; Joung DK; Kim YS; Kang OH; Kim SB; Seo YS; Kim YC; Lee DS; Shin DW; Kweon KT; Kwon DY
    Phytomedicine; 2013 Jun; 20(8-9):714-8. PubMed ID: 23537748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureus.
    Hagihara M; Wiskirchen DE; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2012 Jan; 56(1):202-7. PubMed ID: 22006007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic antibacterial effect of apigenin with β-lactam antibiotics and modulation of bacterial resistance by a possible membrane effect against methicillin resistant Staphylococcus aureus.
    Akilandeswari K; Ruckmani K
    Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):74-82. PubMed ID: 28145860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carnosic acid acts synergistically with gentamicin in killing methicillin-resistant Staphylococcus aureus clinical isolates.
    Vázquez NM; Fiorilli G; Cáceres Guido PA; Moreno S
    Phytomedicine; 2016 Nov; 23(12):1337-1343. PubMed ID: 27765353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of the combination of 20-hydroxyecdysone with ampicillin and gentamicin against methicillin-resistant Staphylococcus aureus.
    Kim ES; Jeong SI; Kim JH; Park C; Kim SM; Kim JK; Lee KM; Lee SH; So H; Park R
    J Microbiol Biotechnol; 2009 Dec; 19(12):1576-81. PubMed ID: 20075622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial effects of moxifloxacin and levofloxacin simulating epithelial lining fluid concentrations against community-acquired methicillin-resistant Staphylococcus aureus.
    Lee SY; Fan HW; Sutherland C; DeRyke AC; Nicolau DP
    Drugs R D; 2007; 8(2):69-77. PubMed ID: 17324004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial and synergic effects of gallic acid-grafted-chitosan with β-lactams against methicillin-resistant Staphylococcus aureus (MRSA).
    Lee DS; Eom SH; Kim YM; Kim HS; Yim MJ; Lee SH; Kim DH; Je JY
    Can J Microbiol; 2014 Oct; 60(10):629-38. PubMed ID: 25216286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Azithromycin in a Mouse Pneumonia Model against Hospital-Acquired Methicillin-Resistant Staphylococcus aureus.
    Yamashita Y; Nagaoka K; Kimura H; Suzuki M; Konno S; Fukumoto T; Akizawa K; Kaku N; Morinaga Y; Yanagihara K
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effect of artocarpin on antibacterial activity of some antibiotics against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli.
    Septama AW; Panichayupakaranant P
    Pharm Biol; 2016; 54(4):686-91. PubMed ID: 26427318
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Mohammadi-Berenjestanaki H; Khori V; Shirzad-Aski H; Ghaemi EA
    Microb Drug Resist; 2020 Mar; 26(3):218-226. PubMed ID: 31424323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
    J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial Activity and Antibiotic-Enhancing Effects of Honeybee Venom against Methicillin-Resistant Staphylococcus aureus.
    Han SM; Kim JM; Hong IP; Woo SO; Kim SG; Jang HR; Pak SC
    Molecules; 2016 Jan; 21(1):79. PubMed ID: 26771592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus.
    Singh NB; Yim J; Jahanbakhsh S; Sakoulas G; Rybak MJ
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):363-370. PubMed ID: 29807674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent in vitro synergism of fusidic acid (FA) and berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Liang RM; Yong XL; Duan YQ; Tan YH; Zeng P; Zhou ZY; Jiang Y; Wang SH; Jiang YP; Huang XC; Dong ZH; Hu TT; Shi HQ; Li N
    World J Microbiol Biotechnol; 2014 Nov; 30(11):2861-9. PubMed ID: 25108628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic Antibacterial Effect and Antibacterial Action Mode of Chitosan-Ferulic Acid Conjugate against Methicillin-Resistant Staphylococcus aureus.
    Eom SH; Kang SK; Lee DS; Myeong JI; Lee J; Kim HW; Kim KH; Je JY; Jung WK; Kim YM
    J Microbiol Biotechnol; 2016 Apr; 26(4):784-9. PubMed ID: 26718468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial activity of the plant-derived compounds 23-methyl-6-O-desmethylauricepyrone and (Z,Z)-5-(trideca-4,7-dienyl)resorcinol and their synergy with antibiotics against methicillin-susceptible and -resistant Staphylococcus aureus.
    Joray MB; González ML; Palacios SM; Carpinella MC
    J Agric Food Chem; 2011 Nov; 59(21):11534-42. PubMed ID: 21958238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
    Yoneda A; Thänert R; Burnham CD; Dantas G
    Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synthesis of antibiotic loaded polylactic acid nanoparticles and their antibacterial activity against Escherichia coli O157:H7 and methicillin-resistant Staphylococcus aureus].
    Herrera MT; Artunduaga JJ; Ortiz CC; Torres RG
    Biomedica; 2017 Jan; 37(1):11-21. PubMed ID: 28527243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pithecellobium clypearia extract enriched in gallic acid and luteolin has antibacterial activity against MRSA and reduces resistance to erythromycin, ceftriaxone sodium and levofloxacin.
    Liu C; Huang H; Zhou Q; Liu B; Wang Y; Li P; Liao K; Su W
    J Appl Microbiol; 2020 Oct; 129(4):848-859. PubMed ID: 32301544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro synergistic interaction of 5-O-methylglovanon and ampicillin against ampicillin resistant Staphylococcus aureus and Staphylococcus epidermidis isolates.
    Zhou X; Jia F; Liu X; Yang J; Zhang Y; Wang Y
    Arch Pharm Res; 2011 Oct; 34(10):1751-7. PubMed ID: 22076775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.